Insufficient scRNA-seq data for expression of CRHR1 at single-cell level.
Insufficient scRNA-seq data for expression of CRHR1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 1026.40 | 2528 / 2642 | 0% | 0.00 | 1 / 705 |
uterus | 92% | 212.73 | 157 / 170 | 0% | 0 | 0 / 459 |
prostate | 71% | 100.76 | 173 / 245 | 0% | 0 | 0 / 502 |
skin | 36% | 34.97 | 657 / 1809 | 0% | 0 | 0 / 472 |
breast | 35% | 48.33 | 162 / 459 | 0% | 0.00 | 2 / 1118 |
thymus | 18% | 14.66 | 120 / 653 | 0% | 0 | 0 / 605 |
ovary | 12% | 11.94 | 21 / 180 | 0% | 0.01 | 1 / 430 |
adipose | 8% | 6.27 | 91 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 3% | 3.19 | 50 / 1445 | 0% | 0 | 0 / 183 |
kidney | 3% | 4.81 | 3 / 89 | 0% | 0 | 0 / 901 |
stomach | 1% | 1.35 | 3 / 359 | 0% | 0 | 0 / 286 |
adrenal gland | 1% | 2.07 | 2 / 258 | 0% | 0 | 0 / 230 |
muscle | 1% | 0.50 | 6 / 803 | 0% | 0 | 0 / 0 |
intestine | 0% | 0.26 | 4 / 966 | 0% | 0 | 0 / 527 |
blood vessel | 0% | 0.15 | 2 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lung | 0% | 0 | 0 / 578 | 0% | 0 | 0 / 1155 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071376 | Biological process | cellular response to corticotropin-releasing hormone stimulus |
GO_0010578 | Biological process | regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway |
GO_0035640 | Biological process | exploration behavior |
GO_0051867 | Biological process | general adaptation syndrome, behavioral process |
GO_0048149 | Biological process | behavioral response to ethanol |
GO_1901386 | Biological process | negative regulation of voltage-gated calcium channel activity |
GO_2000852 | Biological process | regulation of corticosterone secretion |
GO_0007565 | Biological process | female pregnancy |
GO_0051458 | Biological process | corticotropin secretion |
GO_0042596 | Biological process | fear response |
GO_0006955 | Biological process | immune response |
GO_0007190 | Biological process | activation of adenylate cyclase activity |
GO_0030325 | Biological process | adrenal gland development |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0007567 | Biological process | parturition |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0005768 | Cellular component | endosome |
GO_0043404 | Molecular function | corticotropin-releasing hormone receptor activity |
GO_0008528 | Molecular function | G protein-coupled peptide receptor activity |
GO_0051424 | Molecular function | corticotropin-releasing hormone binding |
GO_0005515 | Molecular function | protein binding |
GO_0015056 | Molecular function | corticotrophin-releasing factor receptor activity |
Gene name | CRHR1 |
Protein name | Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1) Corticotropin releasing hormone receptor variant 1f Corticotropin releasing hormone receptor variant 1e Corticotropin releasing hormone receptor 1 (Corticotropin-releasing factor receptor 1) CRF1 receptor isoform I variant B (Corticotropin-releasing factor receptor 1) Corticotropin-releasing factor receptor 1 Corticotropin releasing hormone receptor variant 1g Corticotropin releasing hormone receptor 1 CRH receptor 1 variant B (Corticotropin releasing hormone receptor 1) (Corticotropin-releasing factor receptor 1) Corticotropin-releasing factor receptor 1 isoform j CRF1 receptor isoform I (Corticotropin releasing hormone receptor 1) |
Synonyms | CRFR CRFR1 CRHR |
Description | FUNCTION: G-protein coupled receptor for CRH (corticotropin-releasing factor) and UCN (urocortin). Has high affinity for CRH and UCN. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and down-stream effectors, such as adenylate cyclase. Promotes the activation of adenylate cyclase, leading to increased intracellular cAMP levels. Inhibits the activity of the calcium channel CACNA1H. Required for normal embryonic development of the adrenal gland and for normal hormonal responses to stress. Plays a role in the response to anxiogenic stimuli. . FUNCTION: G-protein coupled receptor for CRH (corticotropin-releasing factor) and UCN (urocortin). Has high affinity for CRH and UCN. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and down-stream effectors, such as adenylate cyclase. Promotes the activation of adenylate cyclase, leading to increased intracellular cAMP levels. Inhibits the activity of the calcium channel CACNA1H. Required for normal embryonic development of the adrenal gland and for normal hormonal responses to stress. Plays a role in the response to anxiogenic stimuli. . FUNCTION: G-protein coupled receptor for CRH (corticotropin-releasing factor) and UCN (urocortin). Has high affinity for CRH and UCN. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and down-stream effectors, such as adenylate cyclase. Promotes the activation of adenylate cyclase, leading to increased intracellular cAMP levels. Inhibits the activity of the calcium channel CACNA1H. Required for normal embryonic development of the adrenal gland and for normal hormonal responses to stress. Plays a role in the response to anxiogenic stimuli. . |
Accessions | B3SXS2 ENST00000632957.1 ENST00000619154.4 ENST00000352855.9 [P34998-3] Q8NFN9 ENST00000577353.5 [P34998-4] A0A994J7T2 ENST00000632552.1 ENST00000611599.1 ENST00000347197.9 ENST00000633333.1 P34998 ENST00000617446.1 ENST00000632383.1 ENST00000616225.3 ENST00000613260.4 [P34998-1] J3KSM0 K9J956 Q8WXR7 A0A1U6XTF7 A0A0A0MQZ1 H0YFR5 ENST00000314537.10 [P34998-2] J3QQR1 ENST00000580876.6 ENST00000705341.1 ENST00000631395.1 ENST00000621969.2 ENST00000618144.2 ENST00000339069.9 ENST00000617905.4 [P34998-2] A0A0G2JM19 ENST00000616274.4 [P34998-1] ENST00000615345.4 [P34998-3] ENST00000614143.4 Q8WXR5 ENST00000398285.7 [P34998-1] J3QKP8 ENST00000616748.4 [P34998-3] B3TIK8 A0A994J7S2 ENST00000633723.1 [P34998-4] J9JIC6 Q8WXR6 ENST00000618382.4 [P34998-2] |